l General Information |
Product Name | Tioconazole |
General description | Tioconazole is an antifungal medication with an average IC50 of 1.7 μM. |
Synonym | UK-20349; 1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole |
Purity | ≥98.0%(HPLC) | CAS Number | 65899-73-2 |
Formula | C16H13Cl3N2OS | Molecular Weight | 387.703 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or almost White Solid |
Solubility(25°C) | DMSO | ≥45mg/mL |
Ethanol | ≥45mg/mL |
Water | Very slightly soluble |
l Biological Information |
Biochem/Physiol
Actions | Tioconazole is a synthetic imidazole derivative, fungicidal Terconazole inhibits cell wall synthesis by inhibiting the biosynthesis of ergosterol or other sterols, damaging the fungal cell membrane, altering its permeability, and promoting loss of essential intracellular elements. Tioconazole is active against pathogenic Candida. |
Application | 1.14-alpha Demethylase Inhibitors 2.Antifungal Agents |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
